Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
357.65
0.00 (0.00%)
Feb 3, 2025, 4:00 PM EST - Market closed
Bio-Rad Laboratories Revenue
Bio-Rad Laboratories had revenue of $649.73M in the quarter ending September 30, 2024, with 2.79% growth. This brings the company's revenue in the last twelve months to $2.58B, down -5.15% year-over-year. In the year 2023, Bio-Rad Laboratories had annual revenue of $2.67B, down -4.67%.
Revenue (ttm)
$2.58B
Revenue Growth
-5.15%
P/S Ratio
n/a
Revenue / Employee
$321,321
Employees
8,030
Market Cap
9.75B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.67B | -130.99M | -4.67% |
Dec 31, 2022 | 2.80B | -120.30M | -4.12% |
Dec 31, 2021 | 2.92B | 376.92M | 14.81% |
Dec 31, 2020 | 2.55B | 233.97M | 10.12% |
Dec 31, 2019 | 2.31B | 22.24M | 0.97% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 63.17B |
AbbVie | 56.33B |
Novartis AG | 51.72B |
AstraZeneca | 51.21B |
Thermo Fisher Scientific | 42.88B |
Abbott Laboratories | 41.95B |
BIO.B News
- 8 days ago - Bio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025 - Business Wire
- 27 days ago - Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests - Business Wire
- 4 weeks ago - Bio-Rad's Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference - Business Wire
- 2 months ago - Bio-Rad's Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference - Business Wire
- 3 months ago - Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference - Business Wire
- 3 months ago - Bio-Rad Laboratories, Inc. (BIO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Bio-Rad Laboratories beats quarterly profit estimates on strong sales in diagnostics unit - Reuters
- 3 months ago - Bio-Rad Reports Third-Quarter 2024 Financial Results - Business Wire